The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
22-Apr-25
Pending
$1.8 billion
Target:
Olympus Energy
Acquiror:
EQT
Advising EQT, the premier large-scale, vertically integrated natural gas company, on the acquisition of Blackstone backed Olympus Energy, a pure play Appalachian based operator
03-Apr-25
Pending
$9.0 billion
Target:
Colonial Enterprises, Inc.
Acquiror:
Brookfield Infrastructure Group LLC
Advising Brookfield Infrastructure Partners LLC on its acquisition of Colonial Enterprises, Inc., which owns and operates the Colonial Pipeline, the largest refined products system in the U.S., spanning ~5,500 miles between Texas and the New York Harbor
26-Feb-25
$100 million
Target:
The Central Basin Platform assets of Lime Rock Resources IV, LP
Acquiror:
Ring Energy, Inc.
Advised Ring Energy on its acquisition of the Central Basin Platform assets of Lime Rock Resources IV, LP
04-Feb-25
Pending
$1.1 billion
Target:
PRISM Vision Group
Acquiror:
McKesson Corporation
Advising PRISM Vision Group, a leading medical eye care services company, on its majority stake sale to McKesson Corporation, a diversified healthcare services and distribution leader
08-Jan-25
$160 million
Target:
EMG Medallion Delaware Crude
Acquiror:
Plains All American (NASDAQ: PAA)
Advising The Energy & Minerals Group on its Sale of Delaware Basin Crude Assets to Plains All American, a publicly traded master limited partnership which operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids and natural gas
04-Dec-24
$542 million (CAD value)
Target:
Heartland Generation
Acquiror:
TransAlta Corporation
Strategic advisor to Heartland Generation, one of Alberta's largest power generators and an Energy Capital Partners affiliate, on its sale to TransAlta Corporation
13-Nov-24
Pending
Undisclosed
Target:
Centogene GmbH
Acquiror:
Charme Capital Partners
Advising Charme Capital Partners, a European mid-market private equity fund, on the acquisition of Centogene GmbH, a leading provider of pharmaceutical solutions and diagnostic tests for rare diseases
29-Jul-24
Undisclosed
Target:
APA Corporation Midland Basin Minerals and Royalties Interests
Acquiror:
Post Oak Energy Capital, LP
Advised Post Oak Energy Capital, a Houston-based, energy-focused private equity firm, on the acquisition of Midland Basin Minerals and Royalties Assets from APA Corporation, an independent oil and gas producer
01-Jul-24
Undisclosed
Target:
Medical Review Institute of America
Acquiror:
Parthenon Capital
Advised Medical Review Institute of America, a portfolio company of Summit Partners and a leading provider of outsourced utilization management and clinical review solutions to payors, on its strategic growth investment from Parthenon Capital
24-Jun-24
$875 million
Target:
Durango Permian
Acquiror:
Kinetik Holdings
Advised Durango Midstream, an owner and operator of natural gas gathering & processing infrastructure, and Morgan Stanley Energy Partners (“MSEP”) on the sale of Durango Permian LLC to Kinetik Holdings Inc. (NYSE: KNTK), a premier midstream operator in the Delaware Basin
08-May-24
$800 million
Target:
U.S. Acute Care Solutions
Advised U.S. Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on the refinancing of its senior secured notes
06-May-24
Pending
Undisclosed
Target:
Veen Bosch & Keuning
Acquiror:
Simon & Schuster
Advising Veen Bosch & Keuning, the largest book publisher in the Netherlands, on its sale to Simon & Schuster, one of the world’s preeminent publishing houses
05-Feb-24
Pending
Undisclosed
Target:
Equity Interest in ARM Energy Trading
Acquiror:
Tokyo Gas America
Advising Tokyo Gas America on the acquisition of a 49% equity interest stake in ARM Energy Holding’s producer services and wholesale commodity trading business, ARM Energy Trading. Tokyo Gas America is an energy company that engages in a wide range of businesses, including operated gas and oil assets, midstream, downstream, power generation, natural gas distribution, and LNG exportation
15-Jan-24
Pending
$1.29 billion
Target:
QuarterNorth Energy Inc.
Acquiror:
Talos Energy Inc.
Advising Talos Energy, an independent exploration and production company, on the acquisition of QuarterNorth Energy, a privately held offshore Gulf of Mexico E&P operator with working interests in several prolific deepwater U.S. Gulf of Mexico assets
15-Dec-23
Pending
$2.7 billion
Target:
Rockcliff Energy II LLC
Acquiror:
TG Natural Resources
Advising TG Natural Resources on the acquisition of Rockcliff Energy II LLC, a portfolio company of Quantum Energy Partners (“Quantum”). Rockcliff is a premier natural gas company in the prolific East Texas Haynesville shale and one of the top natural gas producers in the state of Texas. TG Natural Resources is a Houston based, private E&P company with operations focused in the Haynesville Shale and majority owned by Tokyo Gas
13-Dec-23
Pending
Undisclosed
Target:
Vopak Moda Houston
Acquiror:
Exolum
Advising Exolum on its acquisition of 50% interest in Vopak Moda Houston, a leading ammonia and NGL storage & export terminal, from Moda Midstream (Encap Flatrock-Backed)
14-Nov-23
Undisclosed
Target:
Minerals and Royalties Interest
Acquiror:
Undisclosed
Advised a company on the sale of its minerals and royalties interests in the Appalachian Basin
01-Jun-23
Pending
Undisclosed
Target:
Interest in Joint Venture with CarepathRx Health System Solutions
Acquiror:
The Cigna Group
Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary
23-Jan-23
Pending
$200 million
Target:
Clinigen Ltd’s Proleukin
Acquiror:
Iovance Biotherapeutics
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies
30-Dec-22
$153 million
Target:
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
Acquiror:
Mayne Pharma
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma
02-Nov-22
Undisclosed
Target:
Medallion Delaware Basin, LLC
Acquiror:
Cardinal Midstream Partners
Advised Medallion Midstream and The Energy & Minerals Group on the sale of Medallion Delaware, a newly-built natural gas gathering & processing system in the heart of the Delaware Basin, to Cardinal Midstream Partners
11-Oct-22
$7.9 billion
Target:
Westinghouse Electric Company
Acquiror:
Brookfield Renewable Partners and Cameco
Advised the Independent Committee of Brookfield Renewable Partners, the flagship listed renewable power company of Brookfield Asset Management, in consortium with Cameco and other institutional partners, on the acquisition of Westinghouse Electric Company, one of the world’s largest nuclear services businesses, from Brookfield Business Partners
19-Aug-22
$2.2 billion
Target:
GI Alliance
Acquiror:
Apollo Hybrid Value Fund
Advising the management and majority physician owners of GI Alliance, the largest gastroenterology practice in the United States, on its recapitalization and buyout of minority partner, Waud Capital
23-May-22
$220 million
Target:
Greenbacker Group LLC
Acquiror:
Greenbacker Renewable Energy Company
Advised the Special Committee on the acquisition of the management function currently being performed by Greenbacker Capital Management, an SEC-registered investment adviser, and certain affiliated companies into GREC’s wholly-owned subsidiary, Greenbacker Renewable Energy Corporation. As a result of the Acquisition, Greenbacker will operate as a fully integrated and internally managed company with its own internal executive management team and other employees to manage its business and operations
05-May-22
Undisclosed
Target:
Airtower Networks
Acquiror:
DIF Capital Partners
Advised Airtower Networks on its strategic growth capital raise from DIF Capital Partners